Geri
GNI Group Ltd (GNIIF) Kazanmak
GNIIF Hisse Senedi Fiyat Grafiği
GNIIF Kazanmak
GNI Group Ltd
$15.5
0%
$0
Kapanışta: Mar 25, 16:00:00 GMT-4
$15.5
0%
$0
Sonrası Piyasa: Mar 25, 17:58:57 GMT-4
Son Finansal Sonuçlar: Q4 '25
Raporlandı: 2026-02-13
Geçmiş Kazançlar
Dönemlik
Yıllık
EPS
Gelir
Earnings FAQ
GNIIF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
GNI Group Ltd GNIIF'ün son çeyrekteki geliri nasıl performans gösterdi?
GNI Group Ltd'in gelir tahmini nedir?
GNI Group Ltd'in kazanç kalite puanı nedir?
GNI Group Ltd kazançlarını ne zaman rapor eder?
GNI Group Ltd'in beklenen kazançları nelerdir?
GNI Group Ltd kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$15.5
Açılış fiyatı
$15.5
Günün Aralığı
$15.5 - $15.5
52 haftalık aralık
$12.02 - $19.88
İşlem hacmi
100
Ort.Hacim
3
Dividend yield
--
EPS (TTM)
-0.02
Piyasa Değeri
$863.1M
GNI GROUP LTD nedir?
GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2007-08-31. The firm conducts global pharmaceutical research and development, manufacturing and distribution and biomaterials business. The firm operates in two business segments. The Pharmaceuticals segment conducts research and development, manufacturing, and sale of developed compounds, including ETUARY sold in the China market and Hydronidone (F351), which is in clinical trials. The main products also include other pharmaceuticals and reagents. The Medical Devices segment develops, manufactures, and sells medical devices such as biomaterials in the United States. This segment also includes medical device Designated Marketing Authorization Holder (DMAH) and In-Country Caretaker (ICC) services. The firm also conducts clinical and business development in the United States and conducts clinical development of F351 for Metabolic Dysfunction-Associated Steatohepatitis in the United States.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.